BIOLIFE SOLUTIONS INC (ticker: BLFS) is an NASDAQ-listed electromedical & electrotherapeutic apparatus company. DredgeCap's structured extraction of BLFS's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. BLFS reported $6.19M in revenue and $1.19M for the period ending 2014-12-31, with operating cash flow of -$491K. Cash and equivalents stood at $22.82M (down 65.9% year-over-year). Total assets of $400.91M exceed total liabilities of $28.68M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BLFS SEC Filings
Full cached SEC EDGAR filing history for BLFS, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.